NexGel (NXGL) Stock Price, News & Analysis

Company Overview

NexGel, Inc. (NASDAQ: NXGL) is a development-stage materials science company focused on the research and commercialization of advanced polymer formulations tailored for additive manufacturing and 3D printing applications. Leveraging proprietary expertise in polymer chemistry, NexGel develops high-performance materials designed to meet rigorous mechanical, thermal, and chemical resistance requirements across diverse end markets.

The company’s product pipeline includes custom-engineered resins, powders and elastomeric systems optimized for a range of additive manufacturing processes, including selective laser sintering (SLS), stereolithography (SLA) and fused deposition modeling (FDM). NexGel’s materials aim to enhance part durability, surface finish and functional performance, enabling manufacturers and designers to accelerate prototyping and scale the production of complex components.

Headquartered in the United States, NexGel has pursued strategic partnerships with contract manufacturers, original equipment manufacturers (OEMs) and research institutions to drive material adoption into existing industrial workflows. The company continues to expand its geographic reach and technical capabilities as it works toward broader commercial deployment of its proprietary polymer solutions.

Key Stats

• Today's Range: $0.50 to $0.57
• 50-Day Range: $0.51 to $1.15
• 52-Week Range: $0.48 to $2.89
• Volume: 121,311 shs
• Average Volume: 342,930 shs
• Market Capitalization: $4.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.00
• Consensus Rating: Hold

NexGel Stock Analysis - MarketRank™

NexGel scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

NexGel has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

NexGel has a consensus price target of $2.00, representing about 291.4% upside from its current price of $0.51.

Amount of Analyst Coverage

NexGel has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of NexGel is -1.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of NexGel is -1.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

NexGel has a P/B Ratio of 0.85. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.78% of the float of NexGel has been sold short.

Short Interest Ratio / Days to Cover

NexGel has a short interest ratio ("days to cover") of 0.62, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in NexGel has recently increased by 175.82%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

NexGel does not currently pay a dividend.

Dividend Growth

NexGel does not have a long track record of dividend growth.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: -0.10

News Sentiment

NexGel has a news sentiment score of -0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for NexGel this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, NexGel insiders have not sold or bought any company stock.

Percentage Held by Insiders

20.55% of the stock of NexGel is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

2.21% of the stock of NexGel is held by institutions.

Company Calendar

• Last Earnings: 5/14/2026
• Today: 5/19/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:NXGL
• CIK: 1468929
• Web: nexgel.com
• Phone: 215-702-8550
• Fax: N/A
• Employees: 10
• Year Founded: 1974

Price Target and Rating

• Average Price Target for NexGel: $2.00
• High Price Target: $2.00
• Low Price Target: $2.00
• Potential Upside/Downside: +291.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.40)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3 million
• Net Margins: -28.54%
• Pretax Margin: -27.40%
• Return on Equity: -64.29%
• Return on Assets: -29.64%

Debt

• Debt-to-Equity Ratio: 0.45
• Current Ratio: 1.70
• Quick Ratio: 1.02

Sales & Book Value

• Annual Sales: $11.27 million
• Price / Sales: 0.40
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.60 per share
• Price / Book: 0.85

Miscellaneous

• Outstanding Shares: 8,850,000
• Free Float: 7,255,000
• Market Cap: $4.52 million
• Optionable: Not Optionable
• Beta: 0.74